Skip to main content

Cyteir Therapeutics, Inc. (CYT)

NASDAQ: CYT · IEX Real-Time Price · USD
17.43 -0.72 (-3.97%)
Oct 22, 2021 4:00 PM EDT - Market closed

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Year20202019
Selling, General & Admin
4.183.35
Research & Development
16.7712.77
Operating Expenses
20.9416.11
Operating Income
-20.94-16.11
Other Expense / Income
-0.12-1.07
Pretax Income
-20.82-15.04
Net Income
-20.82-15.04
Net Income Common
-20.82-15.04
Shares Outstanding (Basic)
54
Shares Outstanding (Diluted)
54
Shares Change
18.66%-
EPS (Basic)
-3.99-3.42
EPS (Diluted)
-3.99-3.42
Free Cash Flow Per Share
-3.72-4.02
EBITDA
-20.47-14.83
EBIT
-20.82-15.04
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).